PuSH - Publication Server of Helmholtz Zentrum München: A pathogenic role for Th22/IL-22 in atopic dermatitis is established by a placebo-controlled trial with an anti IL-22/ILV-094 mAb.

Navigation

Home

Deutsch

Research

Advanced Search

Browse by ...

... Journal

... Publication Type

... Research Data

... Publication Year

Publication overview

Support & Contact

Contact persons

Help

Data protection

Guttman-Yassky, E.* ; Khattri, S.* ; Brunner, P.M.* ; Neumann, A.U. ; Malik, K.A.* ; Fuentes-Duculan, J.* ; Garcet, S.* ; Suárez-Fariñas, M.* ; Lebwohl, M.* ; Krueger, J.G.*

A pathogenic role for Th22/IL-22 in atopic dermatitis is established by a placebo-controlled trial with an anti IL-22/ILV-094 mAb.

J. Invest. Dermatol. 137, S53-S53 (2017)

Open Access Green as soon as Postprint is submitted to ZB.

Abstract
Metrics
Extra information

Additional Metrics?

[➜Log in]

Edit extra informations Login

Publication type Article: Journal article

Document type Meeting abstract

Corresponding Author

ISSN (print) / ISBN 0022-202X

e-ISSN 1523-1747

Journal Journal of Investigative Dermatology, The

Quellenangaben Volume: 137, Issue: 5, Pages: S53-S53

Publisher Elsevier

Publishing Place New York, NY

Non-patent literature Publications

Reviewing status Peer reviewed

Institute(s) Institute of Environmental Medicine (IEM)